Clinical Trial Update: Study of Adefovir Dipivoxil for Korean Patients With Chronic Hepatitis B(CHB) Who Have Completed ADF 103814 [Phase 4]

View source ↗

Summary

Phase 4 study of adefovir dipivoxil in Korean patients with chronic hepatitis B who completed prior study ADF 103814; results were posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis B

Drugs mentioned

• Hepsera (adefovir dipivoxil)

Snippet

Sponsor: GlaxoSmithKline | Conditions: Hepatitis B, Chronic, Chronic Hepatitis B | Phase 4 | Status: COMPLETED | Results posted: 2010-11-24